Nourkeyhani H, Den Haese PJ, Porwood S, Hanekamp D, Johnson M and Wang ES. Targeting autophagy as a therapeutic strategy in acute myeloid leukemia. 58th American Society of Hematology annual meeting. San Diego, CA. 2016
Nourkeyhani H and Chen H. PD-L1 as a biomarker predictive of response to checkpoint inhibition in lung cancer. Journal of targeted therapies in cancer (2017). Published online: http://www.targetedonc.com/publications/targeted-therapies-cancer/2016/2016-december/pdl1-as-a-biomarker-predictive-of-response-to-checkpoint-inhibition-in-lung-cancer
Nourkeyhani H and Wang ES. Treatment of older patients with acute myeloid leukemia (AML), in: Acute leukemia: an illustrated guide to diagnosis and treatment. Springer Publishing Company. Editors: Emadi A and Karp J. Submitted.
Pokuri VK, Nourkeyhani H, Bodie B, Herbst L, Sikorski M, Spangenthal E, Fabiano A, George S. Strategies to circumvent testosterone surge and disease flare in advances prostate cancer: Emerging treatment paradigms. JNCCN (2015).13(7):e49-55.
Nourkeyhani H, George S. Immune checkpoint inhibitors for renal cell carcinoma. Journal of Targeted Therapies in Cancer (2014). Published online: http://www.targetedonc.com/publications/targeted-therapies-cancer/2014/october-2014/Immune-Checkpoint-Inhibitors-for-Renal-Cell-Carcinoma#sthash.jwWJV1Pr
Kaushik P, Ghate K, Nourkeyhani H, Farber MG, Kremer JM. Pure ocular mucous membrane pemphigoid in a patient with spondyloarthritis (HLA-B27 positive). Rheumatology. 2013. 10:1093
Iwasaki K, Bajenova E, Somogyi-Ganss E, Miller M, Nguyen V, Nourkeyhani H, Gao Y, Wendel M, Ganss B. Amelotin--a Novel Secreted, Ameloblast-specific Protein. J Dent Res. 2005 Dec;84(12):1127-32.
Gao Y, Jheon A, Nourkeyhani H, Kobayashi H. Molecular cloning, structure, expression, and chromosomal localization of the human Osterix (SP7) gene. Gene. 2004 Oct 27;341:101-10.